Matches in SemOpenAlex for { <https://semopenalex.org/work/W2770887413> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2770887413 abstract "Background The Xpert MTB/RIF is a point of care, fully-automated diagnostic molecular test that simultaneously detects tuberculosis and rifampicin drug resistance which is used as a surrogate for multidrug resistant tuberculosis (MDR-TB). However, not much is known about susceptibility to other anti-TB drugs in patients having Rifampicin susceptibility on the Xpert. The Indian National Tuberculosis Programme recommends isoniazid and rifampicin in the continuation phase as part of category I first line therapy. However, in cases with isoniazid monoresistance, which may be missed by the Xpert MTB/Rif, this would lead to rifampicin monotherapy and possible amplification of resistance. Hence it is essential to know the background rates for isoniazid resistance, before deciding on the drugs to be used in the continuation phase. Aim To analyse drug susceptibility patterns (DST) in patients with rifampicin susceptibility. Methods This study was carried out at the microbiology laboratory of PD Hinduja National Hospital, Mumbai, India. All Mycobacterium tuberculosis (MTB) isolates who underwent 14 drug susceptibility testing (DST) between December 2015- November 2016 were analysed retrospectively. All drugs were tested at WHO defined critical concentrations (CC). Results Of a total of 2750 samples undergoing 14 drug DST, 1383 (50.29%) were rifampicin susceptible. Among the rifampicin susceptible isolates, the most common resistance was observed to Isoniazid (INH) in 182 (13.1%) samples of which 127 (9.18%) were isoniazid monoresistant. Ofloxacin resistance was seen in 55 (3.97%) samples; of these 33 (2.38%) were also moxifloxacin resistant at CC of 0.5 mcg/ml. Polydrug resistance was seen in 71 (5.1%) isolates; of these the most common cross resistance involved INH and Ethionamide seen in 55 (3.97%) isolates. Concomitant INH and fluoroqiunolone resistance was seen in 11 (0.8%) isolates. Concomitant resistance to INH, Pyrazinamide and Ethambutol was seen in 2 isolates. Conclusion Complete DST, when available, can identify polydrug resistance and help design a more effective regimen. Increased access to Line probe assays would identify isoniazid resistance even in patients showing rifampicin susceptibility on the Xpert MTB/Rif. With high rates of INH resistance observed (13.1%) in our setting, it may be prudent to include Ethambutol in the continuation phase to avoid rifampicin monotherapy." @default.
- W2770887413 created "2017-12-04" @default.
- W2770887413 creator A5016038412 @default.
- W2770887413 creator A5027030170 @default.
- W2770887413 creator A5040407662 @default.
- W2770887413 creator A5070960178 @default.
- W2770887413 creator A5071907743 @default.
- W2770887413 creator A5087133173 @default.
- W2770887413 date "2017-11-15" @default.
- W2770887413 modified "2023-09-25" @default.
- W2770887413 title "P11 How expert is the xpert mtb/rif for drug susceptible tuberculosis?" @default.
- W2770887413 doi "https://doi.org/10.1136/thoraxjnl-2017-210983.153" @default.
- W2770887413 hasPublicationYear "2017" @default.
- W2770887413 type Work @default.
- W2770887413 sameAs 2770887413 @default.
- W2770887413 citedByCount "0" @default.
- W2770887413 crossrefType "proceedings-article" @default.
- W2770887413 hasAuthorship W2770887413A5016038412 @default.
- W2770887413 hasAuthorship W2770887413A5027030170 @default.
- W2770887413 hasAuthorship W2770887413A5040407662 @default.
- W2770887413 hasAuthorship W2770887413A5070960178 @default.
- W2770887413 hasAuthorship W2770887413A5071907743 @default.
- W2770887413 hasAuthorship W2770887413A5087133173 @default.
- W2770887413 hasBestOaLocation W27708874131 @default.
- W2770887413 hasConcept C114851261 @default.
- W2770887413 hasConcept C126322002 @default.
- W2770887413 hasConcept C142724271 @default.
- W2770887413 hasConcept C159047783 @default.
- W2770887413 hasConcept C2776967927 @default.
- W2770887413 hasConcept C2777025531 @default.
- W2770887413 hasConcept C2777975735 @default.
- W2770887413 hasConcept C2778607973 @default.
- W2770887413 hasConcept C2778836808 @default.
- W2770887413 hasConcept C2781069245 @default.
- W2770887413 hasConcept C501593827 @default.
- W2770887413 hasConcept C71924100 @default.
- W2770887413 hasConcept C86803240 @default.
- W2770887413 hasConcept C89423630 @default.
- W2770887413 hasConcept C98274493 @default.
- W2770887413 hasConceptScore W2770887413C114851261 @default.
- W2770887413 hasConceptScore W2770887413C126322002 @default.
- W2770887413 hasConceptScore W2770887413C142724271 @default.
- W2770887413 hasConceptScore W2770887413C159047783 @default.
- W2770887413 hasConceptScore W2770887413C2776967927 @default.
- W2770887413 hasConceptScore W2770887413C2777025531 @default.
- W2770887413 hasConceptScore W2770887413C2777975735 @default.
- W2770887413 hasConceptScore W2770887413C2778607973 @default.
- W2770887413 hasConceptScore W2770887413C2778836808 @default.
- W2770887413 hasConceptScore W2770887413C2781069245 @default.
- W2770887413 hasConceptScore W2770887413C501593827 @default.
- W2770887413 hasConceptScore W2770887413C71924100 @default.
- W2770887413 hasConceptScore W2770887413C86803240 @default.
- W2770887413 hasConceptScore W2770887413C89423630 @default.
- W2770887413 hasConceptScore W2770887413C98274493 @default.
- W2770887413 hasLocation W27708874131 @default.
- W2770887413 hasOpenAccess W2770887413 @default.
- W2770887413 hasPrimaryLocation W27708874131 @default.
- W2770887413 hasRelatedWork W1964114557 @default.
- W2770887413 hasRelatedWork W2031773247 @default.
- W2770887413 hasRelatedWork W2068793758 @default.
- W2770887413 hasRelatedWork W2080988841 @default.
- W2770887413 hasRelatedWork W2098842727 @default.
- W2770887413 hasRelatedWork W2099457508 @default.
- W2770887413 hasRelatedWork W2115564547 @default.
- W2770887413 hasRelatedWork W2142030067 @default.
- W2770887413 hasRelatedWork W2155498694 @default.
- W2770887413 hasRelatedWork W2236721674 @default.
- W2770887413 hasRelatedWork W2286961111 @default.
- W2770887413 hasRelatedWork W2381096427 @default.
- W2770887413 hasRelatedWork W2390119401 @default.
- W2770887413 hasRelatedWork W2437976000 @default.
- W2770887413 hasRelatedWork W2567259167 @default.
- W2770887413 hasRelatedWork W2613895053 @default.
- W2770887413 hasRelatedWork W2777236058 @default.
- W2770887413 hasRelatedWork W3174246457 @default.
- W2770887413 hasRelatedWork W3196376472 @default.
- W2770887413 hasRelatedWork W69001215 @default.
- W2770887413 isParatext "false" @default.
- W2770887413 isRetracted "false" @default.
- W2770887413 magId "2770887413" @default.
- W2770887413 workType "article" @default.